株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

皮膚科診断装置・治療薬の世界市場:産業分析、市場規模、シェア、成長率、動向、予測

Dermatology Diagnostic Devices and Therapeutics Market (Dermatoscopes, Microscopes and Trichoscopes, and Imaging Equipment) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

発行 Transparency Market Research 商品コード 455246
出版日 ページ情報 英文 105 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
皮膚科診断装置・治療薬の世界市場:産業分析、市場規模、シェア、成長率、動向、予測 Dermatology Diagnostic Devices and Therapeutics Market (Dermatoscopes, Microscopes and Trichoscopes, and Imaging Equipment) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
出版日: 2018年04月03日 ページ情報: 英文 105 Pages
概要

当レポートでは、世界の皮膚科診断装置市場について調査し、世界市場の現在の状況・将来の見通し、製品、薬剤クラス、パイプライン評価、および地域別の市場シェア分析、ならびに主要企業のプロファイルなどを提供しています。

第1章 序論

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション・市場定義
  • 市場ダイナミクス
  • ポーターのファイブフォース分析
  • 企業の市場シェア
  • 市場魅力分析
  • 皮膚疾患の概要

第4章 世界の皮膚科診断装置市場区分:製品別

  • イントロダクション
  • 世界の皮膚科診断装置市場:製品別
  • 世界のダーマトスコープ市場収益
  • 世界の皮膚科マイクロスコープ・トライスコープ市場収益
  • 世界の皮膚科画像装置市場収益

第5章 世界の皮膚科治療薬市場区分:薬剤クラス別

  • イントロダクション
  • 世界の皮膚科治療市場:薬剤クラス別
    • 世界の皮膚科向け抗菌剤市場収益
    • 世界の皮膚科向け抗ウィルス薬市場収益
    • 世界の皮膚科向けコルチコステロイド市場収益
    • 世界の皮膚科向けレチノイド市場収益
    • 世界の皮膚科向け免疫抑制剤市場収益
    • 世界の皮膚科向け生物製剤市場収益

第6章 市場区分:パイプライン評価別

  • 世界の皮膚科治療市場:パイプライン概要、第1相、第2相、第3相
  • 世界の皮膚科治療市場:パイプライン分析・予測

第7章 世界の皮膚科診断装置・治療市場の区分:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・北アフリカ
  • その他 (RoW)

第8章 過去の概況・現在の動向

第9章 企業プロファイル

図表

List of Tables

  • Table 01 : Global Dermatology Diagnostic Devices Market, by Product, (US$ Mn), 2014-2024
  • Table 02 : Global Dermatoscopes Market Revenue, by Product, (US$ Mn), 2014-2024
  • Table 03 : Global Microscopes and Trichoscopes Market Revenue, by Product, (US$ Mn), 2014-2024
  • Table 04 : Global Imaging Equipment Market Revenue, by Product, (US$ Mn) , 2014-2024
  • Table 05 : Global Dermatology Therapeutics Market, by Drug Class, (US$ Mn), 2014-2024
  • Table 06 : Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)
  • Table 07 : Global Dermatology Diagnostic Devices Market Revenue, by Region, (US$ Mn), 2014-2024
  • Table 08 : Global Dermatology Therapeutics Market Revenue, by Region, (US$ Mn), 2014-2024
  • Table 09 : North America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 10 : North America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014-2024
  • Table 11 : North America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 12 : North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 13 : North America Dermatology Imaging Equipment Market Revenue, by Product Type, 2014-2024 (US$ Mn)
  • Table 14 : North America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 15 : North America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014-2024
  • Table 16 : Europe Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 17 : Europe Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014-2024
  • Table 18 : Europe Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 19 : Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 20 : Europe Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 21 : Europe Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 22 : Europe Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014-2024
  • Table 23 : APAC Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 24 : Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014-2024
  • Table 25 : Asia Pacific Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 26 : Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 27 : Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 28 : Asia Pacific Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 29 : Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014-2024
  • Table 30 : Latin America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 31 : Latin America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014-2024
  • Table 32 : Latin America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 33 : Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 34 : Latin America Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 35 : Latin America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 36 : Latin America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014-2024
  • Table 37 : MENA Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 38 : MENA Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014-2024
  • Table 39 : MENA Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 40 : MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 41 : MENA Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • Table 42 : MENA Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
  • Table 43 : MENA Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014-2024

List of Figures

  • Figure 01 : Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, by Revenue (US$ Mn), 2014-2024
  • Figure 02 : Global Dermatology Diagnostic Devices Market, by Product (US$ Mn), 2015
  • Figure 03 : Global Dermatology Therapeutics Market, by Drug Class (US$ Mn), 2015
  • Figure 04 : Global Market Share, by Region (Diagnostic Devices) (Value %), 2015 and 2024
  • Figure 05 : Global Market Share, by Region (Therapeutics), (Value %), 2015 and 2024
  • Figure 06 : Percentage of Population (U.S., China, Japan, and India) over the age of 65: 1980-2050
  • Figure 07 : Global Percentage Change in the World's Population, by Age: 2010-2050
  • Figure 08 : Market Share Analysis of Key Players, Dermatology Diagnostic Devices Market (%), 2015
  • Figure 09 : Market Share Analysis of Key Players, Dermatology Therapeutics Market (%), 2015
  • Figure 10 : Market Attractiveness Analysis, by Device, 2015
  • Figure 11 : Market Attractiveness Analysis, by Drug Class, 2015
  • Figure 12 : Market Attractiveness Analysis, by Geography, 2015
  • Figure 13 : Global Dermatoscopes Market Revenue (US$ Mn), 2014-2024
  • Figure 14 : Global Microscopes and Trichoscopes Market Revenue (US$ Mn), 2014-2024
  • Figure 15 : Global Imaging Equipment Market Revenue (US$ Mn), 2014-2024
  • Figure 16 : Global Antibacterials Market Revenue (US$ Mn), 2014-2024
  • Figure 17 : Global Antifungal Agents Market Revenue (US$ Mn), 2014-2024
  • Figure 18 : Global Antiviral Agents Market Revenue (US$ Mn), 2014-2024
  • Figure 19 : Global Corticosteroids Market Revenue (US$ Mn), 2014-2024
  • Figure 20 : Global Retinoids Market Revenue (US$ Mn), 2014-2024
  • Figure 21 : Global Immunosuppressants Market Revenue (US$ Mn), 2014-2024
  • Figure 22 : Global Biologics Market Revenue (US$ Mn), 2014-2024
  • Figure 23 : RoW Dermatology Diagnostic Devices Market Revenue, (US$ Mn), 2014-2024
  • Figure 24 : RoW Dermatology Therapeutics Market Revenue, (US$ Mn), 2014-2024
目次

Title:
Dermatology Diagnostic Devices and Therapeutics Market
(Diagnostic Devices - Dermatoscopes (Contact Oil Immersion Dermatoscopes, Cross-polarized Dermatoscopes, and Hybrid Dermatoscopes), Microscopes and Trichoscopes (Multispectral Photoacaustic Microscopy (PAM), Reflectance Confocal Microscopy (RCM), and Raman Spectroscopy), and Imaging Equipment (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, and Optical Coherence Tomography (OCT)); Drug Class - Antibacterial Agents, Antifungal Agents, Antiviral Agents, Corticosteroids, Retinoids, Immunosuppressants, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024.

Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology

This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global dermatology diagnostic devices and therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global dermatology diagnostic devices and therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types of diagnostic devices and therapeutics. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of acute skin conditions, chronic skin conditions, skin infections and other dermatology diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Dermatology Diagnostic Devices and Therapeutics Market: Segmentation

Based on product type, the global dermatology diagnostic devices market has been segmented dermatoscopes, microscopes & trichoscopes, and imaging equipment. These segments are further categorized into sub-segments such as contact oil immersion devices, cross-polarized devices and hybrid devices in dermatoscope segment; multispectral confocal microscope, reflectance confocal microscope, Raman spectroscope, and others in dermatology microscopes and trichoscopes segment; and imaging equipment are sub-segmented into x-ray, magnetic resonance imaging, ultrasound, optical coherence tomography, and others.

Based on the drug class, global dermatology therapeutics market is sub-segmented into antibacterial agents, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppressant, and biologics.

Geographically, the global dermatology diagnostic devices and therapeutics market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, Japan, India, Australia, Brazil, Egypt, Kuwait, Saudi Arabia, and UAE.

Dermatology Diagnostic Devices and Therapeutics Market: Vendor Analysis

The report also profiles major players in the dermatology diagnostic devices and therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc., LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Valeant Pharmaceuticals International, Inc., Canfield Scientific, Inc.

Global Dermatology Diagnostic Devices Market, by Product Type

  • Dermatoscopes
    • Contact Oil Immersion Dermatoscope
    • Cross-Polarized Dermatoscopes
    • Hybrid Dermatoscope
  • Microscopes and Trichoscopes
    • Multispectral Photoacaustic Microscopy (PAM)
    • Reflectance Confocal Microscopy (RCM)
    • Raman Spectroscopy
    • Others
  • Imaging Equipment
    • X-ray
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound
    • Optical Coherence Tomography (OCT)
    • Others

Global Dermatology Therapeutics Market, by Drug Class

  • Antibacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppressants
  • Biologics

Global Dermatology Diagnostic Devices and Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa
    • Egypt
    • Kuwait
    • Saudi Arabia
    • UAE
    • Rest of Middle East & North Africa
  • Rest of the World (RoW)

Table of Contents

Section - 1: Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Research Methodology : Assumptions

Section - 2: Executive Summary: Global Dermatology Diagnostic Devices and Therapeutics Market

  • 2.1. Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2014-2024 (US$ Mn)
  • 2.2. Global Dermatology Diagnostic Devices Market, by Product, 2015 (US$ Mn)
  • 2.3. Global Dermatology Therapeutics Market, by Drug Class, 2015 (US$ Mn)
  • 2.4. Global Market Share by Geography (Diagnostic Devices), 2015 and 2024 (Value %)
  • 2.5. Global Market Share by Geography (Therapeutics), 2015 and 2024 (Value %)
  • 2.6. Dermatology Diagnostic Devices Market Snapshot
  • 2.7. Dermatology Therapeutics Market Snapshot

Section-3: Market Overview: Global Dermatology Diagnostic Devices and Therapeutics Market

  • 3.1. Introduction and Market Definition
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Porter's five forces analysis
  • 3.4. Company Market Share
    • 3.4.1. Company Market Share : Dermatology Diagnostic Devices Market (2015)
    • 3.4.2. Company Market Share : Dermatology Therapeutics Market (2015)
  • 3.5. Market Attractiveness Analysis
    • 3.5.1. Market Attractiveness Analysis : Dermatology Diagnostic Devices Market
    • 3.5.2. Market Attractiveness Analysis : Dermatology Therapeutics Market
    • 3.5.3. Market Attractiveness Analysis : By Geography
  • 3.6. Overview of Skin Diseases

Section-4: Global Dermatology Diagnostic Devices Market Segmentation, By Product

  • 4.1. Introduction
  • 4.2. Global Dermatology Diagnostic Devices Market, by Product, 2014-2024 (US$ Mn)
  • 4.3. Global Dermatoscope Market Revenue 2014-2024 (US$ Mn)
    • 4.3.1. Global Dermatoscope Market Revenue, By Product 2014-2024 (US$ Mn)
  • 4.4. Global Dermatology Microscopes and Trichoscopes Market Revenue 2014-2024 (US$ Mn)
    • 4.4.1. Global Dermatology Microscopes and Trichoscopes Market Revenue, By Product 2014-2024 (US$ Mn)
  • 4.5. Global Dermatology Imaging Equipment Market Revenue 2014-2024 (US$ Mn)
    • 4.5.1. Global Dermatology Imaging Equipment Market Revenue, By Product 2014-2024 (US$ Mn)

Section-5: Global Dermatology Therapeutics Market Segmentation, By Drug Class

  • 5.1. Introduction
  • 5.2. Global Dermatology Therapeutics Market, by Drug Class, 2014-2024 (US$ Mn)
    • 5.2.1. Global Antibacterials for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.2. Global Antifungal Agents for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.3. Global Antiviral Agents for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.4. Global Corticosteroids for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.5. Global Retinoids for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.6. Global Immunosuppresants for Dermatology Market Revenue, 2014-2024 (US$ Mn)
    • 5.2.7. Global Biologics for Dermatology Market Revenue, 2014-2024 (US$ Mn)

Section-6: Market Segmentation - By Pipeline Assessment

  • 6.1. Global Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3
  • 6.2. Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)

Section-7: Global Dermatology Diagnostic Devices and Therapeutics Market Segmentation, By Region

  • 7.1. Overview
    • 7.1.1. Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2014-2024 (US$ Mn)
    • 7.1.2. Global Dermatology Therapeutics Market Revenue, by Geography, 2014-2024 (US$ Mn)
  • 7.2. North America Dermatology Diagnostic Devices and Therapeutics Market
    • 7.2.1. North America Dermatology Diagnostic Devices Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.2.2. North America Dermatology Diagnostic Devices Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.2.2.1. North America Dermatoscope Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.2.2.2. North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.2.2.3. North America Dermatology Imaging Equipment Market Revenue, by Product, 2014-2024 (US$ Mn)
    • 7.2.3. North America Dermatology Therapeutics Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.2.4. North America Dermatology Therapeutics Market Revenue, by Drug Class, 2014-2024 (US$ Mn)
  • 7.3. Europe Dermatology Diagnostic Devices and Therapeutics Market
    • 7.3.1. Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.3.2. Europe Dermatology Diagnostic Devices Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.3.2.1. Europe Dermatoscope Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.3.2.2. Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.3.2.3. Europe Dermatology Imaging Equipment Market Revenue, by Product, 2014-2024 (US$ Mn)
    • 7.3.3. Europe Dermatology Therapeutics Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.3.4. Europe Dermatology Therapeutics Market Revenue, by Drug Class, 2014-2024 (US$ Mn)
  • 7.4. Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market
    • 7.4.1. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.4.2. Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.4.2.1. Asia Pacific Dermatoscope Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.4.2.2. Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.4.2.3. Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product, 2014-2024 (US$ Mn)
    • 7.4.3. Asia Pacific Therapeutics Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.4.4. Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, 2014-2024 (US$ Mn)
  • 7.5. Latin America Dermatology Diagnostic Devices and Therapeutics Market
    • 7.5.1. Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.5.2. Latin America Dermatology Diagnostic Devices Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.5.2.1. Latin America Dermatoscope Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.5.2.2. Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.5.2.3. Latin America Dermatology Imaging Equipment Market Revenue, by Product, 2014-2024 (US$ Mn)
    • 7.5.3. Latin America Dermatology Therapeutics Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.5.4. Latin America Dermatology Therapeutics Market Revenue, by Drug Class, 2014-2024 (US$ Mn)
  • 7.6. Middle East and North Africa (MENA) Dermatology Diagnostic Devices and Therapeutics Market
    • 7.6.1. MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.6.2. MENA Dermatology Diagnostic Devices Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.6.2.1. MENA Dermatoscope Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.6.2.2. MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product, 2014-2024 (US$ Mn)
      • 7.6.2.3. MENA Dermatology Imaging Equipment Market Revenue, by Product, 2014-2024 (US$ Mn)
    • 7.6.3. MENA Dermatology Therapeutics Market Revenue, by Country, 2014-2024 (US$ Mn)
    • 7.6.4. MENA Dermatology Therapeutics Market Revenue, by Drug Class, 2014-2024 (US$ Mn)
  • 7.7. Rest of the World (ROW) Dermatology Diagnostic Devices and Therapeutics Market
    • 7.7.1. ROW Dermatology Diagnostic Devices Market Revenue, 2014-2024 (US$ Mn)
    • 7.7.2. ROW Dermatology Therapeutics Market Revenue, 2014-2024 (US$ Mn)

Section-8: Historical Snapshot and Current Trends

Section-9: Company Profiles

  • 9.1 Agfa-Gevaert N.V.
    • 9.1.1 Company Overview (HQ, Business Segments, Employee Strength)
    • 9.1.2 Financial Overview
    • 9.1.3 Product Portfolio
    • 9.1.4 Strategic Overview
  • 9.2 Astellas Pharma, Inc.
    • 9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Strategic Overview
  • 9.3 Cutera, Inc.
    • 9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Strategic Overview
  • 9.4 Dino-Lite Europe/IDCP BV.
    • 9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.4.2. Product Portfolio
    • 9.4.3. Strategic Overview
  • 9.5 Galderma S.A.
    • 9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.5. Strategic Overview
  • 9.6 Genentech, a Roche Company
    • 9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.6.2. Product Portfolio
    • 9.6.3. Strategic Overview
  • 9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
    • 9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.7.2. Financial Overview
    • 9.7.3. Product Portfolio
    • 9.7.4. Strategic Overview
  • 9.8 LEO Pharma A/S
    • 9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Strategic Overview
  • 9.9 Michelson Diagnostics Ltd.
    • 9.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.9.2. Product Portfolio
    • 9.9.3. Strategic Overview
  • 9.10 Novartis International AG
    • 9.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.10.2. Financial Overview
    • 9.10.3. Product Portfolio
    • 9.10.4. Strategic Overview
  • 9.11 Valeant Pharmaceuticals International, Inc.
    • 9.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.11.2. Financial Overview
    • 9.11.3. Product Portfolio
    • 9.11.4. Strategic Overview
  • 9.12 Canfield Scientific, Inc.
    • 9.12.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 9.12.2. Product Portfolio
    • 9.12.3. Strategic Overview
Back to Top